With a robust clinical-stage pipeline, Agenus harnesses a mix of proprietary antibody platforms, like Retrocyte Exhibit™ and SECANT®, and revolutionary cell therapy techniques, positioning alone as a crucial contributor from the biotechnology and immunotherapy arena.These integrated systems make it possible for for the development of both of tho